Available Credit
11.00 ACPE Pharmacy
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 11.00 credit by the Washington State Pharmacy Association.
This activity is approved for up to 11.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21–L01-P | Activity Type: Live| Start/End date: Fri, 03/24/2023 – 4:00am-Sat, 03/25/2023 – 1:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity – please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
11.00 AMA PRA Category 1 Credit™
Horizon CME designates this Live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
11.00 ANCC
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 11.00 credit.
Details subject to change
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Daylight Time Zone
Friday, March 24, 2023 |
7:00am | Check-in & Breakfast Available in Exhibit Hall |
8:00am | Horizon CME App Overview |
8:05am | Welcome, Introductions, & CE Housekeeping |
8:10am | (01A) Advances in Cancer Drug Therapy: Highlights of New Drugs, Expanding Indications, and Improved Strategies to Optimize Treatment » Rowena (Moe) Schwartz, PharmD, BCOP, FHOPA – University of Cincinnati |
9:10am | (02A) Update on CAR T-Cell Therapy » Tiba Al Sagheer, PharmD, BCOP, BCACP – Miami Cancer Institute | Baptist Health South Florida |
10:10am | Break | Refreshments in Exhibit Hall |
10:45am | (03A) Lessons Learned from Decades of Psychosocial Oncology Nursing Experience: Practical Considerations for Oncology APPs » Debi Boyle, MSN, RN, AOCNS, FAAN – Advanced Oncology Nursing Resources |
11:45am | Gather Lunch |
11:50am | Buffet Lunch & Non-CME/CE Presentation Sponsored by Incyte Corporation / MorphoSys US Inc.: Monjuvi (tafasitamab-cxix) In Combination With Lenalidomide For Use As Second-Line Therapy In Adult Patients With R/R DLBCL » Karolina Faysman, RN, MSN, AOCNP, DNPc – UCLA Medical Center |
12:40pm | Dessert Break – Exhibit Hall |
1:00pm | (04A) Survivorship » Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP – Sylvester Comprehensive Cancer Center |
2:00pm | Break | Refreshments in Exhibit Hall |
2:20pm | (05A) Chronic Lymphocytic Leukemia: Targeting Treatment to Meet Our Patient’s Needs » Katie Tobon, PharmD, BCOP – Moffitt Cancer Center (05B) Clinical Management: Head and Neck Squamous Cell Carcinoma » Yujie Zhao, MD – Mayo Clinic |
3:20pm | (06A) Urgent/Emergent Care Issues in Oncology » Alice Meyer, MPAS, PA-C – Mayo Clinic Cancer Center |
4:20pm | Network Reception in Exhibit Hall |
5:30pm |
Complimentary Dinner Invitation sponsored by Pfizer: An oral treatment combination for adults with unresectable or metastatic melanoma with a BRAF V600E/K mutation » Jeanelle King, PA-C – University of Miami |
Saturday, March 25, 2023 |
7:00am |
Check-in & Exhibit Hall Open |
7:10am | Morning Breakfast Non CME Symposium – Sponsored by Pfizer Oncology: A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation » Kristi Orbaugh, RN, MSN, RNP, AOCN – Community Hospital North Cancer Center |
8:00am | Horizon CME App Overview |
8:05am | Welcome, Introductions, & CE Housekeeping |
8:10am | (07A) Myelodysplastic Syndrome (MDS) Pre and Post-Transplant Considerations » Zhuoer Xie, MD, MSCR – Moffitt Cancer Center » Hany Elmariah, MD, MS – Moffitt Cancer Center (07B) Update on Management of Lung Cancer: An Era of Hope » Rami Manochakian, MD – Mayo Clinic |
9:10am | (08A) Approach to the Anemic Patient » Michael Jaglal, MD – Moffitt Cancer Center (08B) Breast Evaluation and Cancer Treatment » John V. Kiluk, MD, FACS – Moffitt Cancer Center |
10:10am | Break | Refreshments in Exhibit Hall |
10:45am | (09A) What APPs Should Know About Imaging Studies Used to Evaluate Tumor Response in Patients with Cancer » James Costello, MD, PhD – Moffitt Cancer Center |
11:45am | Gather Lunch |
11:50am | Buffet Lunch & Non-CE Symposium Presentation Sponsored by Exelixis: Exelixis Clinical Product Overview for Advanced Practice Providers » Kirollos Hanna, PharmD, BCPS, BCOP – Mayo Clinic College of Medicine and Sciences |
12:40pm | Dessert Break in Exhibit Hall |
1:00pm | (10A) Genetic Testing and Counseling in the Community Setting: Germline and Somatic » Cathy Marinak, APRN, AOCNP – Florida Cancer Specialists & Research Institute |
2:00pm | Concluding Remarks |